Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bluejay Diagnostics, Inc.

NASDAQ: BJDX · Industrial Applications and Services · 5 alerts · CIK 1704287

Share price
$2.29Close, Nov 16
Market cap
$2.56M
Shares outstanding
1.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bluejay Diagnostics, Inc. filings on SEC EDGAR ↗

4:07 PM ET 8-K
Business Update

Bluejay Diagnostics Business Update

Bluejay Diagnostics provided a corporate update for Q3 2026, highlighting the completion of enrollment for its SYMON-II clinical study and the establishment of an alternative manufacturing site ahead of schedule. The company reported a cash balance of $7.38 million and targets an FDA 510(k) submission for its Symphony IL-6 platform in the first half of 2027.

5:01 PM ET 10-Q
Financial Results

Bluejay Diagnostics Q3 2026 Results: Net Loss of $2.01M, Loss Widens

Bluejay Diagnostics reported a net loss of $6.26 million for the nine months ended September 30, 2026, compared to $5.42 million in the prior year period. The company strengthened its cash position to $7.38 million through private placements and warrant exercises, while continuing to invest heavily in research and development for its diagnostic platform.

Key figure
Net loss $2.01M
6:30 AM ET 8-K
Reverse Stock Split

Bluejay Diagnostics Reverse Stock Split

Bluejay Diagnostics implemented a 1-for-4 reverse stock split of its common stock, effective November 3, 2026. The split reduces the number of outstanding shares from approximately 4.47 million to 1.12 million to maintain compliance with Nasdaq listing requirements. Trading will continue under the ticker 'BJDX' with a new CUSIP number.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.